MY193625A - Probiotic composition for treatment or prevention of high blood cholesterol - Google Patents
Probiotic composition for treatment or prevention of high blood cholesterolInfo
- Publication number
- MY193625A MY193625A MYPI2015702828A MYPI2015702828A MY193625A MY 193625 A MY193625 A MY 193625A MY PI2015702828 A MYPI2015702828 A MY PI2015702828A MY PI2015702828 A MYPI2015702828 A MY PI2015702828A MY 193625 A MY193625 A MY 193625A
- Authority
- MY
- Malaysia
- Prior art keywords
- prevention
- treatment
- high blood
- blood cholesterol
- probiotic composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K2035/11—Medicinal preparations comprising living procariotic cells
- A61K2035/115—Probiotics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Heart & Thoracic Surgery (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
A composition capable of reducing total serum cholesterol in a subject upon ingestion comprising Lactobacillus fermentum strain FTDC 8312 in a pharmaceutically effective amount. (No illustrations for abstract)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MYPI2015702828A MY193625A (en) | 2015-08-25 | 2015-08-25 | Probiotic composition for treatment or prevention of high blood cholesterol |
PCT/MY2016/050015 WO2017034389A1 (en) | 2015-08-25 | 2016-03-17 | Probiotic composition for treatment or prevention of high blood cholesterol |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MYPI2015702828A MY193625A (en) | 2015-08-25 | 2015-08-25 | Probiotic composition for treatment or prevention of high blood cholesterol |
Publications (1)
Publication Number | Publication Date |
---|---|
MY193625A true MY193625A (en) | 2022-10-20 |
Family
ID=58100398
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MYPI2015702828A MY193625A (en) | 2015-08-25 | 2015-08-25 | Probiotic composition for treatment or prevention of high blood cholesterol |
Country Status (2)
Country | Link |
---|---|
MY (1) | MY193625A (en) |
WO (1) | WO2017034389A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112877241B (en) * | 2021-02-02 | 2022-02-11 | 浙江大学 | Human lactobacillus fermentum ZJUIDS06 and application thereof |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AUPR101600A0 (en) * | 2000-10-25 | 2000-11-16 | Atheromastat Pty Ltd | Compositions and methods for diagnosis and treatment of cardiovascular disorders |
-
2015
- 2015-08-25 MY MYPI2015702828A patent/MY193625A/en unknown
-
2016
- 2016-03-17 WO PCT/MY2016/050015 patent/WO2017034389A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2017034389A1 (en) | 2017-03-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12017501342A1 (en) | Glycan therapeutics and related methods thereof | |
WO2016086209A8 (en) | Probiotic and prebiotic compositions, and methods of use thereof for treatment of gastrointestinal disorders | |
MY186217A (en) | Mixture of hmos | |
SG10201907660YA (en) | Use of short chain fatty acids in cancer prevention | |
WO2015047941A3 (en) | Compositions and methods for treatment and prophylaxis of gastrointestinal diseases | |
MX2022011742A (en) | Nutritional composition for gastrointestinal environment to provide improved microbiome and metabolic profile. | |
MX2018002543A (en) | Compositions comprising urolithin compounds. | |
EP4086335A4 (en) | Lactobacillus fermentum strain, and composition for preventing or treating metabolic diseases, comprising same | |
EP4086334A4 (en) | Lactobacillus fermentum strain, and composition for preventing or treating metabolic diseases containing same | |
MX2017007654A (en) | Probiotic strains having cholesterol absorbing capacity, methods and uses thereof. | |
PH12017502042A1 (en) | Dietary supplement | |
PH12018550110A1 (en) | Novel probiotic bacterial strain of lactobacillus plantarum and compositions and uses thereof in the treatment of inflammation | |
MX2017015702A (en) | Pharmaceutical and food compositions for inducing satiation and prolonging satiety in subjects in need thereof. | |
WO2020091179A3 (en) | Composition for preventing or treating secondary osteoporosis comprising probiotics as active ingredient | |
WO2015121458A3 (en) | Use of compositions comprising bifidobacterium animalis ssp. lactis lmg p-28149 | |
PH12019501439A1 (en) | Use of lactic acid bacteria to treat or prevent gestational diabetes mellitus | |
WO2014011564A3 (en) | Compositions and method for treatment and prophylaxis of inflammatory bowel disease | |
WO2020091180A3 (en) | Composition for preventing or treating secondary osteoporosis comprising probiotics as active ingredient | |
MX2017007969A (en) | Lactic acid bacteria and their use for the treatment of mastitis. | |
MX370436B (en) | Pharmaceutical composition for use in the treatment or prevention of vitamin and mineral deficiencies in patients which have been subjected to gastric bypass-surgery. | |
MY193625A (en) | Probiotic composition for treatment or prevention of high blood cholesterol | |
MX2021010219A (en) | Composition for use in the prevention and/or treatment of dysbiosis. | |
JP2016003187A5 (en) | ||
MX2020013860A (en) | Lactobacillus plantarum compositions and uses thereof. | |
MX2020007906A (en) | Composition comprising new lactobacillus salivarius strains and method for the prevention and treatment of otitis and upper respiratory infections. |